News Roundup: February 21 to February 25
Your weekly roundup of the latest news from Drug Topics®.
Drug Delivery: The Sky is Not the Limit
The use of drones to deliver critically important therapies can help overcome the barriers to care that impact patients in metropolitan areas.
AbbVie Submits Supplemental NDA for Vraylar for Adjunctive MDD Therapy
Cariprazine is already approved to treat schizophrenia and bipolar I in adults.
This Week in COVID-19: As New Omicron Variant Circulates, States Lift Mask Mandates
COVID-19 updates and news to know as of February 21, 2022.
Cancer and COVID-19: Solving the Puzzle of Vaccination
Recent treatment may affect the antibody response, particularly among those with hematologic cancers.
Efficacy Outcomes of Some Cancer Biosimilars Indistinguishable Vs Reference Product
Findings from a systematic review found little difference in outcomes between biosimilar and reference product treatment options.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
